The government has suggested five years for shelf life of all medical devices in the draft released on 19th October. These regulations have been disliked on many grounds because of shelf life of medical devices suggested in the draft.

A senior government official said if the government could reconsider this proposal that they might consider temporary audit and evaluation of the equipment to decide whether an extension on the shelf life can be given. The decision on extending the shelf life will be done on a case to case basis.

In Indian conditions, the shelf life of medical devices is only up to five years so this period is suggested in the draft, a senior government official explained. The industry argues, orthopaedic implants are an example having more than 5years shelf life medical device.

The recent letter to the Secretary of the Department (Pharmaceuticals) as reviewed and stated, “CDSCO Inspectors will take years to develop the needful ability to assess the diverse nature of manufacturing technologies involved ranging from electronics to radiation to metallurgy to microbiology to implants, plastics, rubbers, steels, chemistry, genetics, nano science etc. and to develop from an inspector quality control mindset to a risk mitigation quality management mindset needed for this innovative diverse engineering industry to thrive.” The government decided to build different medical devices regulations as it was widely felt that devices should be treated differently from drugs.

Business Standard

Other News

Imports of High-Value Medical Equipment

High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]

Read More

SEC Committee: Pioneering Medical Approvals

New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]

Read More
  • ErlySign's Oral Cancer Detection

ErlySign Oral Cancer Detection Technology Gets CDSCO Nod

ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]

Read More

Additional Steps Announced by FDA to Modernize Clinical Trials

The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]

Read More

Accreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA 

This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]

Read More

BSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing

BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]

Read More

TUV SUD Inspects IVD Medical Devices’ Cyber Security

The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]

Read More

TGA Supports MHRA’s New Regulations

The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]

Read More